|
BSPM, DTGI, BOCX, UNLA, BBDA, AMHD
Our Stocks to Watch today include Biostar Pharmaceuticals Inc. (NASDAQ: BSPM), Digerati Technologies Inc. (OTCBB: DTGI), BioCurex Inc. (OTCBB: BOCX), Unilava Corp. (OTCBB: UNLA), Bebida Beverage Co. (OTC: BBDA) and Amelot Holdings Inc. (OTC: AMHD).
BIOSTAR PHARMACEUTICALS INCORPORATED (NASDAQ: BSPM)
"Up 56.07% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/BSPM.php
Biostar Pharmaceuticals, Inc., through its wholly owned subsidiary and controlled affiliate in China, develops, manufactures and markets pharmaceutical and health supplement products for a variety of diseases and conditions. The Company's most popular product is its Xin Aoxing Oleanolic Acid Capsule, an over-the-counter ("OTC") medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population.
BSPM News:
June 13 - Biostar Pharmaceuticals, Inc. and Fmmu to Jointly Conduct Phases I To III Clinical Trials for Viacom Drug
Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced that it signed a Letter of Intent ("LOI") with The Fourth Military Medical University ("FMMU") to jointly conduct Phases I to III clinical trials for Viacom Pine II Cream ("Viacom") drug. The LOI has been submitted to China's military authorities for approval.
Viacom is a prescription drug developed by the First Affiliated Hospital of Dermatology of FMMU specifically for the needs of China's military and will be used to treat skin diseases such as bacterial and fungal infections, dermatitis and eczema. Viacom has passed all standard tests related to quality, stability, toxicology and efficiency. Phases I to III clinical trials must be conducted for a period of three years prior to receiving final approval from military authorities to start production.
FMMU is one of China's most prestigious military medical universities and research centers and its primary purpose is to advance China's military medicine. In January 2012, Biostar was one of nine PRC pharmaceutical companies selected to cooperate with FMMU in the fields of research and product development.
According to the terms of the LOI, FMMU will be responsible for:
* Submitting applications and receiving approvals to commence clinical trials; coordinating with China's military authorities during clinical trials and securing all needed approvals to continue Phases I to III of these clinical trials for the next three years at FMMU's facilities; securing final production approvals by October 2015; and providing the technology to ensure the quality and effectiveness of the product.
Biostar will be responsible for:
* Coordinating with FMMU to complete the clinical trials before October 2015; bearing all costs of clinical trials and approvals; completing the construction of the production line and obtaining the GMP certification on time; and manufacturing the drug using the technology provided by FMMU.
Ronghua Wang, Biostar's Chief Executive Officer and Chairman, commented, "Following the initial clinical research, Viacom has demonstrated encouraging results for the treatment of several skin diseases such as bacterial and fungal infections, dermatitis and eczema which are common among members of the PRC armed forces. Additionally, these types of skin diseases affect a large portion of China's population and, if not treated properly, could result in severe health complications. Once Viacom receives approval from the military authorities to be sold in military hospitals, we will apply to receive SFDA's approval to sell it in health care centers and hospitals all over the country."
Mr. Wang continued, "This LOI follows the Cooperation Agreement we signed in January 2012, according to which Biostar was selected to work with FMMU's staff to share resources and ideas and to carry out Phases I to IV of clinical trials for products which, when approved, will be sold directly to China's military and to the three hospitals managed by FMMU. We are targeting additional LOIs with FMMU to conduct clinical trials for new products, which will help us become a production base for manufacturing drugs specifically for the needs of China's military."
DIGERATI TECHNOLOGIES INCORPORATED (OTCBB: DTGI)
"Up 84.71% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/DTGI.php
Digerati Technologies, Inc. engages in the provision of cloud telephony services worldwide. The company offers global voice over Internet protocol (VoIP) services; and cloud-based hosted services, including IP/PBX services, IP trunking, call center applications, prepaid services, interactive voice response auto attendant, call recording, simultaneous calling, voicemail to email conversion, and customized IP/PBX for specialized applications. It provides its services to carriers, telephony resellers, and other VoIP carriers over the Internet. The company was formerly known as ATSI Communications Inc. and changed its name to Digerati Technologies, Inc. in March, 2011. Digerati Technologies, Inc. was founded in 1993 and is headquartered in San Antonio, Texas.
DTGI News:
No recent news for Digerati Technologies, Inc. (OTCBB: DTGI).
BIOCUREX INCORPORATED (OTCBB: BOCX)
"Up 50.00% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/BOCX.php
BioCurex, Inc. is a biotechnology company that is developing products based on patented and proprietary technology in the area of cancer diagnostics. The technology identifies a universal cancer marker known as RECAF. RECAF is a molecule that is present on cancer cells but not detected in significant levels on healthy cells or benign tumor cells. It is the receptor for alpha-fetoprotein and is classified as an oncofetal antigen due to its presence on both fetal and malignant tissues. This characteristic makes RECAF a more accurate indicator of cancer than most current tumor markers. BioCurex is commercializing its technology through licensing arrangements with companies that develop and market diagnostic tests for the large automated clinical laboratory setting, through development and marketing of non-automated clinical laboratory tests, through development of rapid, point-of-care test formats, and through marketing of its OncoPet RECAF test for cancer in companion animals.
BOCX News:
May 31 - BioCurex Announces Investment Into the Company by Paulson Investment Company
BioCurex Inc. (OTCBB: BOCX) announced that the Company received a commitment from Paulson Investment Company Inc. to make an investment in a long-term convertible note. The proceeds from which will be specifically used to prepay the principal, interest and penalties on the Company's short-term debt obligation due on June 15th, 2012.
In January 2010, Paulson Investment Company, Inc. served as the lead underwriter of the Company's public offering.
"As we work toward commercializing our RECAF technology and expanding our OncoPet platform to include test kits for cats, it is important we have the funding to continue to execute on our business plan and satisfy our financial obligations," stated Dr. Ricardo Moro, CEO of BioCurex. "Paulson has been of great support to BioCurex and we truly appreciate their level of confidence in our Company."
Chester (Chet) Paulson, Founder and Chairman of Paulson Investment, stated, "We believe in the Company's technology and we are pleased to be able to continue to support BioCurex. Paulson will continue to support innovative companies like BioCurex."
UNILAVA CORPORATION (OTCBB: UNLA)
"Up 49.25% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/UNLA.php
Unilava Corporation and its subsidiary brands provide a variety of communications services, products, and equipment that address the needs of small to enterprise businesses and consumers. The company is licensed to provide long distance services in 41 States and local phone services in 11 States. Through its carrier-grade microwave wireless broadband infrastructure and broadband Internet access partners, the company offers mobile and high-definition IP-hosted voice services to residential, small and medium enterprises. The company delivers small business a comprehensive and integrated suite of fee-based online and mobile advertising and web services. Headquartered in San Francisco, the company has regional offices in Chicago, Seoul, Hong Kong, and Beijing.
UNLA News:
No recent news for Unilava Corporation (OTCBB: UNLA).
BEBIDA BEVERAGE COMPANY (OTC: BBDA)
"Up 33.33% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/BBDA.php
BeBevCo (Bebida Beverage Company) develops, manufactures and markets beverages including Koma Unwind "Chillaxation Drink™," Koma Unwind Sugar-free "Chillaxation Drink™," and Koma Unwind "Chillaxation Shot™" as well as Potencia Energy Drink, Potencia "BLAST" energy shot and Piranha Water.
BBDA News:
June 1 - Relaxation Drink Maker BeBevCo Executes Deal with CEFCO to Carry Koma Unwind in 257 Stores in 7 States across the Southern U.S.
Bebida Beverage Company (OTC: BBDA) (BeBevCo) a developer, manufacturer and marketer of relaxation and energy drinks and supplements announced today that CEFCO Convenience stores will begin carrying Koma Unwind regular and sugar free Relaxation drinks in over 250 stores across the southern U.S. CEFCO Stores are an independently owned chain of convenience stores based in Temple, TX. There are 257 locations across Alabama, Arkansas, Louisiana, Mississippi, New Mexico, Oklahoma and Texas. CEFCO has been serving their customers since 1979.
ABOUT CEFCO
CEFCO Stores is an independently owned chain of convenience stores based in Temple, TX. CEFCO has 257 locations across Alabama, Arkansas, Louisiana, Mississippi, New Mexico, Oklahoma and Texas. CEFCO's founder, Clarence Edison Fikes, was born in Cameron, TX. Fikes Wholesale, Inc. was founded in 1952 as a single Texaco service station in Mr. Fikes' hometown, where he would also later turn his attention to the wholesale fuel business. In 1979, retail fuel and grocery became the focus when he opened the first CEFCO Convenience Store. Today, CEFCO is the 57th largest convenience store chain in the United States, and remains a family owned operation.
"This is the largest retail partner we have announced to date. It is our objective to cover the entire U.S. with our products. While we have made tremendous progress over the last few months in the northeastern portion of the country, this particular deal gets our products into over 250 stores in the southern U.S.," said Brian Weber, CEO of BeBevCo. "Distributor by distributor, chain by chain and store by store we will achieve our objective. These type additions yield big dividends for our company on the bottom line all while giving the customers what they want and need," Weber added.
"Progressive and forward thinking chains stores like CEFCO are true trend setters and are determining the pace in which consumers around the USA and world get the opportunity to have a Liquid solution to their stress, anxiety and sleep issues," offered COO Daisy Ramirez.
AMELOT HOLDINGS INCORPORATED (OTC: AMHD)
"Up 100.00% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/AMHD.php
Amelot Holdings, Inc. (www.amelotholdings.com), a publicly traded company, is a diversified holding company that has identified Biodiesel as a $20 billion emerging market. Amelot plans to have a significant market share in growing low cost feedstocks to supply the growing demand for biodiesel, to reduce energy dependency of fossil fuels, to help reduce the U.S. dependency on foreign oil supplies and reduce the impact of energy on our environment.
AMHD News:
No recent news for Amelot Holdings, Inc. (OTC: AMHD).
|
